Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes

被引：1
|
作者：
Mies, Anna [1 ]
Bozic, Tanja [2 ]
Kramer, Michael [1 ]
Franzen, Julia [2 ]
Ehninger, Gerhard [1 ]
Bornhauser, Martin [1 ,3 ]
Platzbecker, Uwe [1 ,3 ]
Wagner, Wolfgang [2 ]
机构：
[1] Univ Hosp Carl Gustav Carus Dresden, Dept Internal Med 1, Dresden, Germany
[2] RWTH Aachen Med Sch, Helmholtz Inst Biomed Engn, Stem Cell Biol & Cellular Engn, Aachen, Germany
[3] German Canc Consortium, Heidelberg, Germany
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3194.3194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3194
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Myelodysplastic Syndromes Classification and Risk Stratification
    Komrokji, Rami S.
    Zhang, Ling
    Bennett, John M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) : 443 - +
  • [2] Updates in Risk Stratification in Myelodysplastic Syndromes
    Aguirre, Luis E.
    Sallman, David A.
    Stone, Richard
    Komrokji, Rami S.
    CANCER JOURNAL, 2023, 29 (03): : 138 - 142
  • [3] Risk Stratification of Myelodysplastic Syndromes - Is There Room for Improvement?
    Marques, Barbara Almeida
    Silva, Duarte Pacheco
    Santos, Joao Gaiao
    Moura, Pedro Pinho
    Ana Teresa Simoes, Catia Almeida
    Oliveira, Ana Catarina
    Coucelo, Margarida
    Cortesao, Emilia
    Geraldes, Catarina
    BLOOD, 2022, 140 : 12319 - 12320
  • [4] Editorial: Risk-stratification in myelodysplastic syndromes
    Breccia, Massimo
    Vinchi, Francesca
    Bonifacio, Massimiliano
    Binotto, Gianni
    Zheng, Gang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Cytogenetic Risk Stratification in Myelodysplastic Syndromes: Are We There Yet?
    Pardanani, Animesh
    Tefferi, Ayalew
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2703 - 2704
  • [6] Current state of prognostication and risk stratification in myelodysplastic syndromes
    Zeidan, Amer M.
    Gore, Steven D.
    Padron, Eric
    Komrokji, Rami S.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (02) : 146 - 154
  • [7] The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes
    DeZern, Amy E.
    Greenberg, Peter L.
    BLOOD, 2023, 142 (26) : 2258 - 2267
  • [8] Risk stratification in therapy-related myelodysplastic syndromes
    Zeidan, Amer M.
    ONCOTARGET, 2017, 8 (46) : 80103 - 80104
  • [9] Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management
    Garcia-Manero, Guillermo
    Chien, Kelly S.
    Montalban-Bravo, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (11) : 1399 - 1420
  • [10] Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling?
    Zeidan, Amer M.
    Prebet, Thomas
    Aldin, Ehab Saad
    Gore, Steven David
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) : 191 - 194
12345